Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REMIMAZOLAM vs REQUIP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REMIMAZOLAM vs REQUIP: Safety Overview

Metric REMIMAZOLAM REQUIP
Total FAERS Reports 137 157
Deaths Reported 3 6
Death Rate 2.2% 3.8%
Hospitalizations 24 37
Average Patient Age 60.4 yrs 64.8 yrs
% Female Patients 41.5% N/A
FDA Approval Date Oct 6, 2020 N/A
Manufacturer Acacia Pharma, Ltd. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A